BACKGROUND: The integration of psycho-oncology into the medical care of cancer patients requires a transparent, reliable, and valid assessment of psychosocial stress. The Basic Documentation for Psycho-Oncology (PO-Bado), including a short version and a breast cancer-specific version, is such an instrument. The purpose of this article is to present the current stage of development of the 3 versions. PATIENTS AND METHODS: All versions of the PO-Bado were developed and psychometrically evaluated based on the empirical analysis of multiple oncological samples. External criteria for the validation and determination of cut-off scores were the Hospital Anxiety and Depression Scale, the Questionnaire on Stress in Cancer Patients, and the EORTC Quality of Life Questionnaire. Inter-rater reliability was examined by different psycho-oncologists who independently rated PO-Bado interviews. RESULTS: Three versions of the PO-Bado are presented: the standard version (PO-Bado, 17 items), the short form (PO-Bado SF, 7 items), and the breast cancer-specific version (PO-Bado BC, 21 items). A manual and interview guideline are provided for all versions. By now, the standard version has been implemented throughout Germany and includes data of 6,365 patients. CONCLUSION: A consistent nationwide implementation of the PO-Bado for the assessment of psychosocial stress in cancer patients would contribute to the improvement of medical care.
BACKGROUND: The integration of psycho-oncology into the medical care of cancerpatients requires a transparent, reliable, and valid assessment of psychosocial stress. The Basic Documentation for Psycho-Oncology (PO-Bado), including a short version and a breast cancer-specific version, is such an instrument. The purpose of this article is to present the current stage of development of the 3 versions. PATIENTS AND METHODS: All versions of the PO-Bado were developed and psychometrically evaluated based on the empirical analysis of multiple oncological samples. External criteria for the validation and determination of cut-off scores were the Hospital Anxiety and Depression Scale, the Questionnaire on Stress in CancerPatients, and the EORTC Quality of Life Questionnaire. Inter-rater reliability was examined by different psycho-oncologists who independently rated PO-Bado interviews. RESULTS: Three versions of the PO-Bado are presented: the standard version (PO-Bado, 17 items), the short form (PO-Bado SF, 7 items), and the breast cancer-specific version (PO-Bado BC, 21 items). A manual and interview guideline are provided for all versions. By now, the standard version has been implemented throughout Germany and includes data of 6,365 patients. CONCLUSION: A consistent nationwide implementation of the PO-Bado for the assessment of psychosocial stress in cancerpatients would contribute to the improvement of medical care.
Authors: K Kirchheiner; A Czajka; E Ponocny-Seliger; C Lütgendorf-Caucig; M P Schmid; E Komarek; R Pötter; W Dörr Journal: Strahlenther Onkol Date: 2013-03-29 Impact factor: 3.621
Authors: K Kirchheiner; A Czajka; E Ponocny-Seliger; E Komarek; G Hohenberg; R Pötter; W Dörr Journal: Strahlenther Onkol Date: 2013-05-25 Impact factor: 3.621
Authors: Anne Grimm; Barbara Voigt; Petra Georgiewa; Thomas Fydrich; Dieter Kleiber; Burghard F Klapp; Martina Rauchfuß Journal: Breast Care (Basel) Date: 2009-10-01 Impact factor: 2.860
Authors: Sabrina Gröpper; Elke van der Meer; Tom Landes; Hubert Bucher; Anna Stickel; Ute Goerling Journal: Support Care Cancer Date: 2015-12-02 Impact factor: 3.359